Laboratory Providers can find the latest information on the virco®TYPE HIV-1 report, as of 23-January-2007

Please click here to listen to an archived presentation hosted by Virco's director of Clinical and Regulatory Affairs, Dr. Tim Alcorn. In this session, Dr. Alcorn provides an overview of upcoming changes to the virco®TYPE HIV-1 reports that are being implemented on January 23, 2008. Key features of the new reports include: Updated Clinical Cut-Offs, a new approach for handling viral mixtures, new mutation lists, and resistance information for Intelence™(etravirine) which recently gained market clearance in the US.